These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7504973)

  • 21. Invasive Haemophilus influenzae serotype B surveillance in Ontario--documenting the progression towards elimination.
    Sciberras J
    Can Commun Dis Rep; 1999 Nov; 25(21):181-4. PubMed ID: 10624034
    [No Abstract]   [Full Text] [Related]  

  • 22. Quarterly communicable disease review January to March 1994. PHLS Communicable Disease Surveillance Centre.
    J Public Health Med; 1994 Sep; 16(3):357-64. PubMed ID: 7999391
    [No Abstract]   [Full Text] [Related]  

  • 23. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):901-6. PubMed ID: 8927012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quarterly communicable disease review April to June 1997. From the PHLS Communicable Disease Surveillance Centre.
    J Public Health Med; 1997 Dec; 19(4):470-5. PubMed ID: 9467156
    [No Abstract]   [Full Text] [Related]  

  • 25. From the Centers for Disease Control and Prevention. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
    JAMA; 1999 Feb; 281(5):409-10. PubMed ID: 9952189
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemophilus influenzae type b disease: prospects for prevention in New Zealand.
    Ameratunga SN; Lennon DR; Martin D
    N Z Med J; 1994 May; 107(978):193-4. PubMed ID: 8196862
    [No Abstract]   [Full Text] [Related]  

  • 27. Surveillance for rare disorders by the BPSU. The British Paediatric Surveillance Unit.
    Verity C; Preece M
    Arch Dis Child; 2002 Oct; 87(4):269-71. PubMed ID: 12243988
    [No Abstract]   [Full Text] [Related]  

  • 28. Quarterly Communicable Disease Review July to September 1993. From the PHLS Communicable Disease Surveillance Centre.
    J Public Health Med; 1994 Mar; 16(1):105-12. PubMed ID: 8037941
    [No Abstract]   [Full Text] [Related]  

  • 29. Changing patterns of infectious diseases.
    Commun Dis Rep CDR Wkly; 1994 Oct; 4(43):203. PubMed ID: 7528603
    [No Abstract]   [Full Text] [Related]  

  • 30. Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia.
    Meekison W; Hutcheon M; Guasparini R; Arnott M; Scheifele D; Grace M; Humphreys G; Barreto L
    Can Dis Wkly Rep; 1989 Jul; 15(28):143-5. PubMed ID: 2791073
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemophilus influenzae: the efficiency of reporting invasive disease in England and Wales.
    Macleod CA
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R13-6. PubMed ID: 7511458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of vaccination for Haemophilus influenzae type b.
    Garner D; Weston V
    Lancet; 2003 Feb; 361(9355):395-6. PubMed ID: 12573380
    [No Abstract]   [Full Text] [Related]  

  • 33. Active surveillance of rare and serious diseases in children.
    Commun Dis Rep CDR Wkly; 2000 Sep; 10(39):349, 352. PubMed ID: 11048426
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pediatric surveillance of invasive infections caused by Haemophilus influenzae type b in children in the period following introduction of vaccination].
    Conyn-van Spaendonck MA; Suijkerbuijk AW; Hirasing RA; van Pelt W
    Ned Tijdschr Geneeskd; 1995 Apr; 139(17):885-90. PubMed ID: 7739737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging infectious diseases--United Kingdom.
    Walford D; Noah N
    Emerg Infect Dis; 1999; 5(2):189-94. PubMed ID: 10221869
    [No Abstract]   [Full Text] [Related]  

  • 36. Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991.
    Broadhurst LE; Erickson RL; Kelley PW
    JAMA; 1993 Jan; 269(2):227-31. PubMed ID: 8417240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
    Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communicable Disease Report October to December 1990. From the PHLS Communicable Disease Surveillance Centre.
    J Public Health Med; 1991 May; 13(2):127-34. PubMed ID: 1854522
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(46):993-8. PubMed ID: 9843325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.